Compliance Question of the Week – Laboratory

What is needed if an ESRD patient is tested more than once a week?

How should I report the first and additional single-probe stain procedures when distinguishing between manual and computer-assisted methods?

What are the intended use of codes 88355–88358?

When do we report +88155 vs 88150 or 88152?

Which code should be reported for the quantitative analysis of a non-specified mononuclear cell antigen via flow cytometry when the cell count is not defined by another code?

What will happen if we bill for an electronic compatibility test on the same claim with 86920 or 86922?

How would we code for a case when aspiration is performed with or without the preparation of smears on a superficial tissue, without radiologic guidance?

A pathology lab is performing an immunofluorescent study on a skin biopsy to evaluate immunoglobulin deposits. They’re using fluorescent-tagged antibodies for IgG, IgM, and C3, with examination under fluorescent microscopy. I understand that 88346 would be reported for the initial study, but if they also perform an additional antibody stain for fibrinogen, how would this be reported?

When is 81528 covered by Medicare part B?

When both qualitative and quantitative antibody tests are performed on the same specimen, should both tests be billed separately, or is only one reportable?

What are the key compliance requirements and challenges associated with standing orders for laboratory services under Medicare regulations?

What are the key compliance requirements and challenges associated with standing orders for laboratory services under Medicare regulations?